Questions?
Contact UsNext-Generation Sequencing of Pediatric Tumor Samples (OncoKids®) from a Multi-Institutional Consortium of Clinical Cancer Programs
Study Details
Next-Generation Sequencing of Pediatric Tumor Samples (OncoKids®) from a Multi-Institutional Consortium of Clinical Cancer Programs
Conditions: Leukemia, Sarcoma, Brain Tumor
Study ID
ONC99117 (CHLA-18-00228)
Study Description
The OncoKids® cancer panel is a primer-based target enrichment, next-generation sequencing assay designed to detect diagnostic, prognostic and biologic markers for targeted therapy across the spectrum of pediatric cancers. These cancers include leukemias, sarcomas, brain tumors and embryonal tumors. OncoKids® is a targeted gene panel intended to guide the diagnosis and treatment of cancer in pediatric patients based on the genomic alterations specific to their tumor.
Eligibility Requirements
NULL
Principal Investigator
More Information
To learn more visit:
NULL
This page was last updated on: 3/30/2026 10:07:27 AM